Submitted by Diana Knight
on
Congratulations to Yuting Zeng, who defended her Ph.D. work “Elucidating Human Disease Mechanisms Using Innovative Open Microfluidic Platforms” on June 17, 2024. Yuting was a student in Professor Ashleigh Theberge’s research group and worked on biomedical applications of multiple open microfluidic devices, including kidney disease, airway inflammation, and wildfire smoke exposure. She has accepted a position as a business operations manager with Absci, a generative AI drug creation company on a mission to create better biologics for patients, faster.